These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34048190)

  • 1. Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma.
    Korn P; Kampmann A; Spalthoff S; Jehn P; Tavassol F; Lentge F; Gellrich NC; Zimmerer R
    Asian Pac J Cancer Prev; 2021 May; 22(5):1591-1597. PubMed ID: 34048190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
    Kanwal R; Shukla S; Walker E; Gupta S
    Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines.
    Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA
    Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.
    Grasso C; Anaka M; Hofmann O; Sompallae R; Broadley K; Hide W; Berridge MV; Cebon J; Behren A; McConnell MJ
    BMC Cancer; 2016 Sep; 16(1):726. PubMed ID: 27613604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.
    Curley MD; Therrien VA; Cummings CL; Sergent PA; Koulouris CR; Friel AM; Roberts DJ; Seiden MV; Scadden DT; Rueda BR; Foster R
    Stem Cells; 2009 Dec; 27(12):2875-83. PubMed ID: 19816957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
    Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM
    Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
    Cells; 2020 May; 9(5):. PubMed ID: 32408542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
    Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
    J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
    Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-135a-induced formation of CD133+ subpopulation with cancer stem cell properties in cervical cancer.
    Leung CON; Deng W; Ye TM; Ngan HYS; Tsao SW; Cheung ANY; Ziru N; Yuen DCK; Pang RTK; Yeung WSB
    Carcinogenesis; 2020 Nov; 41(11):1592-1604. PubMed ID: 32415843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of stem cell marker CD133 expression in colorectal cancer.
    Wang BB; Li ZJ; Zhang FF; Hou HT; Yu JK; Li F
    Histol Histopathol; 2016 Mar; 31(3):299-306. PubMed ID: 26442717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.
    Navarro-Alvarez N; Kondo E; Kawamoto H; Hassan W; Yuasa T; Kubota Y; Seita M; Nakahara H; Hayashi T; Nishikawa Y; Hassan RA; Javed SM; Noguchi H; Matsumoto S; Nakaji S; Tanaka N; Kobayashi N; Soto-Gutierrez A
    Cell Transplant; 2010; 19(6):865-77. PubMed ID: 20587145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD; Zhou L; Cheng L; Tian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep; 42(9):692-6. PubMed ID: 18051573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.